These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22473489)

  • 21. [Antithrombin resistance: a new mechanism of inherited thrombophilia].
    Kojima T; Takagi A; Murata M; Takagi Y
    Rinsho Ketsueki; 2015 Jun; 56(6):632-8. PubMed ID: 26256872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The futility of thrombophilia testing.
    Favaloro EJ
    Clin Chem Lab Med; 2014 Apr; 52(4):499-503. PubMed ID: 23940063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombophilia testing in patients with portal vein thrombosis.
    Kirkeby MH; Larsen JB; Grønbaek H; Hvas AM
    Scand J Clin Lab Invest; 2020 Dec; 80(8):694-698. PubMed ID: 33026843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-vitamin K antagonist oral anticoagulants in patients with severe inherited thrombophilia: a series of 33 patients.
    Undas A; Goralczyk T
    Blood Coagul Fibrinolysis; 2017 Sep; 28(6):438-442. PubMed ID: 28079536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classic thrombophilic gene variants.
    Mannucci PM; Franchini M
    Thromb Haemost; 2015 Nov; 114(5):885-9. PubMed ID: 26018405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated protein C resistance testing for factor V Leiden.
    Kadauke S; Khor B; Van Cott EM
    Am J Hematol; 2014 Dec; 89(12):1147-50. PubMed ID: 25293789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism.
    Rolla R; Pergolini P; Vidali M; Pollarolo P; Appiani A; Cerutti C; Manzini M; Crisci A; Bellomo G
    Clin Lab; 2014; 60(10):1725-33. PubMed ID: 25651720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare case of unprovoked venous thromboembolism manifestation in a young patient with antithrombin Type IIB deficiency combined with inferior vena cava anomaly from Lithuania.
    Saulytė-Trakymienė S; Adomaitienė I; Unkrig S; Oldenburg J; Ivaškevičius V
    Hamostaseologie; 2017; 37(S 01):S26-S31. PubMed ID: 29582922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathology consultation on the laboratory evaluation of thrombophilia: when, how, and why.
    Ballard RB; Marques MB;
    Am J Clin Pathol; 2012 Apr; 137(4):553-60. PubMed ID: 22431530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic issues in thrombophilia: a laboratory scientist's view.
    Favaloro EJ
    Semin Thromb Hemost; 2005 Feb; 31(1):11-6. PubMed ID: 15706470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency.
    Hézard N; Bouaziz-Borgi L; Remy MG; Nguyen P
    Clin Chem; 2006 Apr; 52(4):665-70. PubMed ID: 16469858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.
    Croles FN; Nasserinejad K; Duvekot JJ; Kruip MJ; Meijer K; Leebeek FW
    BMJ; 2017 Oct; 359():j4452. PubMed ID: 29074563
    [No Abstract]   [Full Text] [Related]  

  • 34. Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program.
    Jennings I; Kitchen S; Woods TA; Preston FE
    Semin Thromb Hemost; 2005 Feb; 31(1):66-72. PubMed ID: 15706477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perinatal aspects of inherited thrombophilia.
    Bonnar J; Green R; Norris L
    Semin Thromb Hemost; 1999; 25(5):481-5. PubMed ID: 10625206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH.
    Van Cott EM; Orlando C; Moore GW; Cooper PC; Meijer P; Marlar R;
    J Thromb Haemost; 2020 Jan; 18(1):17-22. PubMed ID: 31894660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inherited and acquired thrombophilias and poor pregnancy outcome: should we be treating with heparin?
    Gebhardt GS; Hall DR
    Curr Opin Obstet Gynecol; 2003 Dec; 15(6):501-6. PubMed ID: 14624217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited Thrombophilia.
    Phillippe HM; Hornsby LB; Treadway S; Armstrong EM; Bellone JM
    J Pharm Pract; 2014 Jun; 27(3):227-33. PubMed ID: 24739277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
    Goldhaber SZ; Eriksson H; Kakkar A; Schellong S; Feuring M; Fraessdorf M; Kreuzer J; Schueler E; Schulman S
    Vasc Med; 2016 Dec; 21(6):506-514. PubMed ID: 27807306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.